Screening of Nutritional Status in Cardiac Surgery

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
Efremov Sergey, Meshalkin Research Institute of Pathology of Circulation
ClinicalTrials.gov Identifier:
NCT01366807
First received: May 31, 2011
Last updated: October 30, 2013
Last verified: October 2013

May 31, 2011
October 30, 2013
January 2011
March 2015   (final data collection date for primary outcome measure)
Mortality [ Time Frame: Participants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
Mortality [ Time Frame: Partitipants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01366807 on ClinicalTrials.gov Archive Site
  • Complications [ Time Frame: Participants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
    Postoperative cardiac failure, infectious complications, clinically significant arrhythmia, bleeding
  • Intensive care unit stay [ Time Frame: Participants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
  • Hospital stay [ Time Frame: Participants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
  • Ventilation time [ Time Frame: Participants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
    Period between admission to ICU after the surgery and extubation
  • Complications [ Time Frame: Partitipants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
    Postoperative cardiac failure, infectious complications, clinically significant arrhythmia, bleeding
  • Intensive care unit stay [ Time Frame: Partitipants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
  • Hospital stay [ Time Frame: Partitipants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
  • Ventilation time [ Time Frame: Partitipants will be followed for the duration of hospital stay, an average of 4 weeks. ] [ Designated as safety issue: No ]
    Period between admission to ICU after the surgery and extubation
Not Provided
Not Provided
 
Screening of Nutritional Status in Cardiac Surgery
Screening of Nutritional Status and Predictors of Adverse Outcome in Cardiac Surgery

Screening of nutritional status is unsolved problem in cardiac surgery. Applicability of such criteria as body mass index and albumin and screening scales (MNA, NRS-2002, SGA, SNAQ) in cardiac surgery is controversial and insufficiently studied. Furthermore, there is some known predictors of poor outcome, which closely related to nutritional status (C-reactive protein, total lymphocyte count). The aim of this study is assessment of several nutritional screening scales, objective nutritional criteria and predictors for the purpose of detection of most informative one or its combination.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

Serum, white cells

Probability Sample

Patients, who live in Russia, mostly in Siberia whom scheduled to cardiac surgery in one institution.

Cardiovascular Diseases
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
3500
August 2015
March 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult patients with cardiovascular disease operated on under cardiopulmonary bypass

Exclusion Criteria:

  • Age under 18 years
  • Emergency
  • Participation in other trial.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Russian Federation
 
NCT01366807
SCR2011
Yes
Efremov Sergey, Meshalkin Research Institute of Pathology of Circulation
Meshalkin Research Institute of Pathology of Circulation
Not Provided
Principal Investigator: Vladimir V Lomivorotov, MD, PhD Novosibirsk Research Institute of Pathology of Circulation
Meshalkin Research Institute of Pathology of Circulation
October 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP